{"id":"W3170554531","doi":"10.1200/jco.2021.39.15_suppl.5541","title":"Patient self-reporting of tolerability using PRO-CTCAE: A randomized double-blind placebo controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in women with platinum resistant epithelial ovarian cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Cancer Care Ontario; Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Tolerability; Placebo; Internal medicine; Gemcitabine; Adverse effect; Nausea; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001970743,0.00131158,0.002558137,0.0004907856,0.0004044848,0.000743259,0.0008273227,0.001736905,0.00624744],"category_scores_gemma":[0.002313798,0.0006908143,0.001346564,0.0005219703,0.000722534,0.0007740821,0.0004068251,0.002215398,0.00073736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004929453,"about_ca_system_score_gemma":0.0007381162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005868596,"about_ca_topic_score_gemma":0.001665654,"domain_scores_codex":[0.9987961,0.000777099,0.0000779036,0.0001810622,0.00008568138,0.00008214969],"domain_scores_gemma":[0.9985417,0.0003687302,0.0005207775,0.00008943734,0.00009037225,0.0003889656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9636571,0.01083969,0.001525652,0.000695343,0.0007789343,0.00002161781,0.00005124023,0.0002656817,0.003600301,0.0000476461,0.0007017566,0.01781486],"study_design_scores_gemma":[0.9069479,0.08604775,0.005400897,0.00002042968,0.0002786289,0.00002446668,0.00001521209,0.0003398591,0.0003201291,0.00005595835,0.0005346546,0.00001417343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806294,0.004507422,0.0008925869,0.0006245478,0.0003649081,0.008116378,0.002394417,0.0001714986,0.002298717],"genre_scores_gemma":[0.9834279,0.001426218,0.001886078,0.0008456937,0.0002855573,0.008926927,0.001337349,0.00002421108,0.001839992],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00624744,"threshold_uncertainty_score":0.02089971,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1365709277447514,"score_gpt":0.449648667628297,"score_spread":0.3130777398835456,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}